01:29 PM EDT, 09/30/2024 (MT Newswires) -- (Adds Kimberly-Clark declines to comment in last paragraph.)

Kimberly-Clark ( KMB ) is mulling options for its international tissue business as part of a strategy to focus on more profitable areas, Bloomberg reported Monday, citing people familiar with the matter.

The company is working with advisers to review its non-North American tissue segment, which may lead to a sale of part or all of the operation, valuing the business at about $4 billion, the report said

Kimberly-Clark ( KMB ) declined to comment to MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 142.50, Change: -0.04, Percent Change: -0.03